Sommaire

Numéro précédent | Numéro suivant

• • ·Addressing the global health security agenda

    Page :257

     
• • ·End of the debate about antiretroviral treatment initiation

    Page :258-259

    Seonaid Nolan, Evan Wood

    
• • ·Shot in the HAART: vaccine therapy for HIV

    Page :259-260

    Merlin L Robb, Jerome H Kim

     
• • ·Changing patterns in meningitis

    Page :261-262

    Elizabeth Molyneux, Adam Finn

     
• • ·Surveillance of hand, foot, and mouth disease for a vaccine

    Page :262-263

    Hiroyuki Shimizu, Kazutoshi Nakashima

    
• • ·Yersinia pestis: one pandemic, two pandemics, three pandemics, more?

    Page :264-265

    M Thomas P Gilbert

     
• • ·Single-tablet, once-daily treatment regimens for HIV

    Page :265-267

    Joshua R Sawyer, Qing Ma, Chiu-Bin Hsiao

    
• • ·Advancing the portfolio of tuberculosis diagnostics, drugs, biomarkers, and vaccines

    Page :267-269

    Alimuddin I Zumla, Marco Schito, Markus Maeurer

    
• • ·Corrections

    Page :269

    
• • ·Drug-resistant Salmonella enterica serotype Kentucky in Europe

    Page :270-271

    Therese Westrell, Dominique L Monnet, Céline Gossner, Ole Heuer, Johanna Takkinen

     
• • ·Clinical epidemiology of Klebsiella pneumoniae carbapenemases

    Page :271-272

    Norman Lippmann, Christoph Lübbert, Thorsten Kaiser, Udo X Kaisers, Arne C Rodloff

     
• • ·Colorectal neoplasia associated with Streptococcus gallolyticus subspecies pasteurianus

    Page :272-273

    Juan Corredoira Sánchez, Fernando García-Garrote, Amparo Coira, Hugo López-Agreda, María Pilar Alonso-García

    
• • ·India after polio

    Page :274-275

    Talha Burki

     
• • ·Highlights from the 21st CROI

    Page :276-277

    Rebecca Cooney, Peter Hayward

    Plan Plan  
• • ·Infectious disease surveillance update

    Page :277

    Neil Bennet

    Plan Plan
• • ·Research brief

    Page :278

    Jane Bradbury

    Plan Plan  
• • ·Tragic and moving stories of MDR tuberculosis

    Page :279

    Raffaella Bosurgi

     
• • ·Infection control throughout history

    Page :280

    David Wright

     
• • ·Effects of early versus delayed initiation of antiretroviral treatment on clinical outcomes of HIV-1 infection: results from the phase 3 HPTN 052 randomised controlled trial

    Page :281-290

    Beatriz Grinsztejn, Mina C Hosseinipour, Heather J Ribaudo, Susan Swindells, Joseph Eron, Ying Q Chen, Lei Wang, San-San Ou, Maija Anderson, Marybeth McCauley, Theresa Gamble, Nagalingeshwaran Kumarasamy, James G Hakim, Johnstone Kumwenda, Jose H S Pilotto, Sheela V Godbole, Suwat Chariyalertsak, Marineide Gonçalves de Melo, Kenneth H Mayer, Susan H Eshleman, Estelle Piwowar-Manning, Joseph Makhema, Lisa A Mills, Ravindre Panchia, Ian Sanne, Joel Gallant, Irving Hoffman, Taha E Taha, Karin Nielsen-Saines, David Celentano, Max Essex, Diane Havlir, Myron S Cohen, the HPTN 052-ACTG Study Team †

    Résumé Résumé Plan Plan   
• • ·Safety and efficacy of the peptide-based therapeutic vaccine for HIV-1, Vacc-4×: a phase 2 randomised, double-blind, placebo-controlled trial

    Page :291-300

    Richard B Pollard, Jürgen K Rockstroh, Giuseppe Pantaleo, David M Asmuth, Barry Peters, Adriano Lazzarin, Felipe Garcia, Kim Ellefsen, Daniel Podzamczer, Jan van Lunzen, Keikawus Arastéh, Dirk Schürmann, Bonaventura Clotet, W David Hardy, Ronald Mitsuyasu, Graeme Moyle, Andreas Plettenberg, Martin Fisher, Gerd Fätkenheuer, Margaret Fischl, Babafemi Taiwo, Ingebjørg Baksaas, Darren Jolliffe, Stefan Persson, Øyvind Jelmert, Arnt-Ove Hovden, Maja A Sommerfelt, Vidar Wendel-Hansen, Birger Sørensen

    Résumé Résumé Plan Plan   
• • ·Trends in bacterial, mycobacterial, and fungal meningitis in England and Wales 2004–11: an observational study

    Page :301-307

    Ifeanichukwu O Okike, Sonia Ribeiro, Mary E Ramsay, Paul T Heath, Mike Sharland, Shamez N Ladhani

    Résumé Résumé Plan Plan  
• • ·Hand, foot, and mouth disease in China, 2008–12: an epidemiological study

    Page :308-318

    Weijia Xing, Qiaohong Liao, Cécile Viboud, Jing Zhang, Junling Sun, Joseph T Wu, Zhaorui Chang, Fengfeng Liu, Vicky J Fang, Yingdong Zheng, Benjamin J Cowling, Jay K Varma, Jeremy J Farrar, Gabriel M Leung, Hongjie Yu

    Résumé Résumé Plan Plan   
• • ·Yersinia pestis and the Plague of Justinian 541–543 AD: a genomic analysis

    Page :319-326

    David M Wagner, Jennifer Klunk, Michaela Harbeck, Alison Devault, Nicholas Waglechner, Jason W Sahl, Jacob Enk, Dawn N Birdsell, Melanie Kuch, Candice Lumibao, Debi Poinar, Talima Pearson, Mathieu Fourment, Brian Golding, Julia M Riehm, David J D Earn, Sharon DeWitte, Jean-Marie Rouillard, Gisela Grupe, Ingrid Wiechmann, James B Bliska, Paul S Keim, Holger C Scholz, Edward C Holmes, Hendrik Poinar

    Résumé Résumé Plan Plan   
• • ·New antituberculosis drugs, regimens, and adjunct therapies: needs, advances, and future prospects

    Page :327-340

    Alimuddin I Zumla, Stephen H Gillespie, Michael Hoelscher, Patrick P J Philips, Stewart T Cole, Ibrahim Abubakar, Timothy D McHugh, Marco Schito, Markus Maeurer, Andrew J Nunn

    Résumé Résumé Plan Plan  
• • ·Strengthening the Reporting of Molecular Epidemiology for Infectious Diseases (STROME-ID): an extension of the STROBE statement

    Page :341-352

    Nigel Field, Ted Cohen, Marc J Struelens, Daniel Palm, Barry Cookson, Judith R Glynn, Valentina Gallo, Mary Ramsay, Pam Sonnenberg, Duncan MacCannell, Andre Charlett, Matthias Egger, Jonathan Green, Paolo Vineis, Ibrahim Abubakar

    Résumé Résumé Plan Plan   
• • ·Loa loa—does it deserve to be neglected?

    Page :353-357

    Wolfram Gottfried Metzger, Benjamin Mordmüller

    Résumé Résumé Plan Plan   
• • ·A high-definition view of endogenous fungal endophthalmitis

    Page :358

    Ian A S Rodrigues, Timothy L Jackson